Some anti-abortion activists have been frustrated by the lack of action on the issue by the Trump administration this year, with many surprised last week when the Food and Drug Administration approved a generic version of mifepristone.

But several fo

📰

Continue Reading on New York Times

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →